SCHEMBL20945362

SCHEMBL20945362

C[Si](C)(C)C#Cc1ccccc1CO

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.43
CYP1A2 P05177 2/20 0.43
CYP3A4 P08684 2/20 0.43
CYP2D6 P10635 2/20 0.43
MAPT P10636 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MEN1 O00255 1/20 0.43
ALDH1A1 P00352 1/20 0.43
HPGD P15428 1/20 0.43
TSHR P16473 1/20 0.43
KMT2A Q03164 1/20 0.43
FFAR1 O14842 4/20 0.42
APOBEC3G Q9HC16 1/20 0.36
PDCD1 Q15116 1/20 0.35
CD274 Q9NZQ7 1/20 0.35
CREBBP Q92793 1/20 0.33
CYP4F2 P78329 1/20 0.31
CYP4A11 Q02928 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29791106 1.00 KDM4E (0.43) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL14992925 0.82 PTGDR2 (0.42) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL3839029 0.79 KDM4E (0.49) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL18945561 0.78 FFAR1 (0.46) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL18946204 0.78 ALDH1A1 (0.38) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL15524054 0.78 KDM4E (0.38) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL12797116 0.77 ALDH1A1 (0.37) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL31064494 0.76 FFAR1 (0.52) FFAR1
SCHEMBL15956362 0.75 CYP1A2 (0.36) KDM4ECYP1A2CYP3A4CYP2D6MAPT
SCHEMBL17729329 0.75 ALDH1A1 (0.45) KDM4ECYP1A2CYP3A4CYP2D6MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11787877-B2 Antibody with non-natural amino acid introduced therein RIKEN (JP) 2023-10-17 US disclosed
CN-114907389-A Boronic acid derivatives 首药控股(北京)股份有限公司 2022-08-16 CN disclosed
US-20210107997-A1 ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN RIKEN (JP) 2021-04-15 US disclosed
US-10906990-B2 Antibody with non-natural amino acid introduced therein RIKEN (JP) 2021-02-02 US disclosed
US-20190127488-A1 ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN RIKEN (JP) 2019-05-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190127488-A1 ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN NSUN3, NSUN2, LNPEP KDM4E 401/4885CYP1A2 4802/4885CYP3A4 4662/4885
US-10906990-B2 Antibody with non-natural amino acid introduced therein NSUN3, NSUN2, LNPEP KDM4E 401/4885CYP1A2 4802/4885CYP3A4 4662/4885
US-20210107997-A1 ANTIBODY WITH NON-NATURAL AMINO ACID INTRODUCED THEREIN NSUN3, NSUN2, LNPEP KDM4E 401/4885CYP1A2 4802/4885CYP3A4 4662/4885
US-11787877-B2 Antibody with non-natural amino acid introduced therein NSUN3, NSUN2, LNPEP KDM4E 401/4885CYP1A2 4802/4885CYP3A4 4662/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.